- Home
- DCI
as 07-26-2024 4:00pm EST
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.4 billion in revenue and $480 million in operating income in its fiscal 2023.
| Founded: | 1915 | Country: | United States |
| Employees: | N/A | City: | BLOOMINGTON |
| Market Cap: | 8.9B | IPO Year: | 1987 |
| Target Price: | $67.67 | AVG Volume (30 days): | 435.4K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.22 | EPS Growth: | 8.42 |
| 52 Week Low/High: | $57.05 - $78.03 | Next Earning Date: | 08-27-2024 |
| Revenue: | $3,530,400,000 | Revenue Growth: | 2.59% |
| Revenue Growth (this year): | 5.84% | Revenue Growth (next year): | 5.32% |
Stock Insider Trading Activity of Donaldson Company Inc. (DCI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Robinson Scott J. | DCI | Chief Financial Officer | Jul 2 '24 | Sell | $70.97 | 37,600 | $2,668,472.00 | 37,702 | SEC Form 4 |
| OBERTON WILLARD D | DCI | Director | Mar 20 '24 | Sell | $73.54 | 4,500 | $330,930.00 | 27,685 | SEC Form 4 |
| Robinson Scott J. | DCI | Chief Financial Officer | Mar 18 '24 | Sell | $73.29 | 31,912 | $2,338,830.48 | 42,790 | SEC Form 4 |
| Robinson Scott J. | DCI | Chief Financial Officer | Mar 18 '24 | Sell | $73.11 | 5,088 | $371,983.68 | 37,702 | SEC Form 4 |
| Kramer Sheila G. | DCI | Chief Human Resources Officer | Mar 15 '24 | Sell | $73.52 | 15,000 | $1,102,800.00 | 23,171 | SEC Form 4 |
| Kramer Sheila G. | DCI | Chief Human Resources Officer | Mar 15 '24 | Sell | $73.52 | 14,500 | $1,066,040.00 | 23,171 | SEC Form 4 |
| Kramer Sheila G. | DCI | Chief Human Resources Officer | Mar 15 '24 | Sell | $73.52 | 16,000 | $1,176,320.00 | 23,171 | SEC Form 4 |
| Rajendra Ajita G | DCI | Director | Mar 7 '24 | Sell | $73.51 | 18,700 | $1,374,637.00 | 41,961 | SEC Form 4 |
| SCALF THOMAS R | DCI | President | Mar 1 '24 | Sell | $71.09 | 7,680 | $545,971.20 | 0 | SEC Form 4 |
| SCALF THOMAS R | DCI | President | Mar 1 '24 | Sell | $73.09 | 3,027 | $221,243.43 | 0 | SEC Form 4 |
| Rajendra Ajita G | DCI | Director | Mar 1 '24 | Sell | $72.23 | 14,000 | $1,011,220.00 | 41,931 | SEC Form 4 |
| OBERTON WILLARD D | DCI | Director | Feb 29 '24 | Sell | $70.41 | 4,500 | $316,845.00 | 27,655 | SEC Form 4 |
| OBERTON WILLARD D | DCI | Director | Jan 2 '24 | Sell | $64.99 | 5,000 | $324,950.00 | 26,337 | SEC Form 4 |
| Rajendra Ajita G | DCI | Director | Dec 11 '23 | Sell | $62.24 | 11,400 | $709,536.00 | 40,545 | SEC Form 4 |
| Briseno Guillermo | DCI | President | Dec 6 '23 | Sell | $61.50 | 2,737 | $168,325.50 | 16,170 | SEC Form 4 |
| Owens James | DCI | Director | Nov 30 '23 | Sell | $60.89 | 11,378 | $692,806.42 | 15,445 | SEC Form 4 |
| Owens James | DCI | Director | Nov 30 '23 | Sell | $60.89 | 22 | $1,339.58 | 15,423 | SEC Form 4 |
Latest Donaldson Company Inc. News
DCI Breaking Stock News: Dive into DCI Ticker-Specific Updates for Smart Investing
Business Wire
4 hours ago
Donaldson Company Declares Quarterly Cash Dividend
Simply Wall St.
a day ago
Is Donaldson Company, Inc. (NYSE:DCI) Trading At A 26% Discount?
Argus Research
3 days ago
DCI: Lowering target price to $77.00
Zacks
7 days ago
Donaldson (DCI) is a Top-Ranked Growth Stock: Should You Buy?
Business Wire
9 days ago
Donaldson Foundation Announces Recipient of $100K Challenge Grant
Argus Research
10 days ago
DCI: Raising target price to $79.00
Business Wire
10 days ago
Donaldson Company, Inc., Through Its Univercells Technologies Business, Expands Their Relationship With the Gene Therapy Program at the University of Pennsylvania to Evaluate Certain Bioreactors for Scalable Gene Therapy Production
Zacks
14 days ago
Here's Why It is Appropriate to Retain Donaldson (DCI) Now
Compare DCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DCI Donaldson Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.